CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹754 Cr | ₹536 Cr | ₹288 Cr | ₹371 Cr | ₹315 Cr |
What is the latest Net Current Assets ratio of CONCORD BIOTECH ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹754 Cr |
Mar2023 | ₹536 Cr |
Mar2022 | ₹288 Cr |
Mar2021 | ₹371 Cr |
Mar2020 | ₹315 Cr |
How is Net Current Assets of CONCORD BIOTECH Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹754 Cr | 40.72 | |
Mar2023 | ₹536 Cr | 85.79 | |
Mar2022 | ₹288 Cr | -22.30 | |
Mar2021 | ₹371 Cr | 17.73 | |
Mar2020 | ₹315 Cr | - |
Compare Net Current Assets of peers of CONCORD BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CONCORD BIOTECH | ₹19,656.4 Cr | -1.9% | 4.6% | 12.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics |
CONCORD BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CONCORD BIOTECH | -1.9% |
4.6% |
12.1% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses